global drug facility

 {Photo credit: Warren Zelman}The MSH-led Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program is co-hosting the Global TB Conference 2015: Building the Post-2015 Agenda with the Stop TB Partnership Global Drug Facility.Photo credit: Warren Zelman
The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, led by Management Sciences for Health (MSH), in collaboration with the Stop TB Partnership Global Drug Facility, will host a technical conference titled, “Building the Post-2015 Agenda: Novel Approaches to Improving Access to TB Medicines and Pharmaceutical Services” from March 2-6, 2015 at the Conrad Bangkok Hotel in Bangkok, Thailand.

The invitation-only conference will feature country experiences using tested approaches to prevent tuberculosis (TB) medicine stock-outs, increase TB case detection through private sector engagement, and ensure patient safety during TB treatment. National TB program (NTP) managers or deputies; NTP procurement and supply management leads; monitoring and evaluation leads for TB/data managers; donors; and World Health Organization and Stop TB Partnership partners are expected to attend.

{Photo credit: Mark Tuschman.}Photo credit: Mark Tuschman.

This post originally appeared on the SIAPS website.

After decades of relying on old medicines, new drugs designed specifically for the treatment of tuberculosis (TB) are finally on the market. While these medicines represent a major advancement in the fight against TB, ensuring equitable access for patients is still an enormous challenge. At the 45th Union World Conference on Lung Health, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program, led by Management Sciences for Health (MSH), collaborated with the Stop TB Partnership Global Drug Facility (GDF) to host a full-day workshop addressing common hurdles to treatment access, as well as available solutions.

The SIAPS program focused on three common challenges in medicines availability: quantification, public-private mixes, and medicines safety.

 {Photo credit: Mark Tuschman.}A pharmacy in Kenya.Photo credit: Mark Tuschman.

Guaranteeing that patients have uninterrupted access to anti-tuberculosis (TB) treatment begins with national TB programs (NTP) making complex calculations about how many cases to expect in the future.  Vigilant stock management, accurate number of cases started on each type of treatment along with forecasting the expected number of patients that will be enrolled on treatment, are vital to ensure that medicines are available to all patients who need them.

To promote a systems-strengthening approach to TB medicines management, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program developed QuanTB—a downloadable, desktop tool that transforms intricate calculations into a user-friendly dashboard displaying key quantification and supply planning information.

Printer Friendly Version
Subscribe to RSS - global drug facility